The board may exempt a particular drug product from the requirements of KRS § 217.907, upon application of a manufacturer or distributor showing that the drug product’s size, texture, or other unique characteristics render imprinting impractical or impossible.
Effective: July 15, 1982

Terms Used In Kentucky Statutes 217.911


History: Created 1982 Ky. Acts ch. 5, sec. 4, effective July 15, 1982.